Anpario (LON:ANP) Shares Down 11.9% – Here’s What Happened

Anpario plc (LON:ANP)’s share price dropped 11.9% during mid-day trading on Wednesday . The company traded as low as GBX 467 and last traded at GBX 480. Approximately 221,767 shares were traded during trading, an increase of 387% from the average daily volume of 45,508 shares. The stock had previously closed at GBX 545.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the company. Canaccord Genuity Group reissued a “buy” rating and issued a GBX 570 price target on shares of Anpario in a research note on Friday, June 26th. Shore Capital Group reissued a “house stock” rating on shares of Anpario in a research report on Monday, August 17th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of GBX 570.

Anpario Trading Down 11.9%

The company has a market cap of £78.17 million, a PE ratio of 12.65 and a beta of 1.08. The company has a debt-to-equity ratio of 0.60, a quick ratio of 5.16 and a current ratio of 4.50. The company has a 50 day simple moving average of GBX 532.43 and a two-hundred day simple moving average of GBX 517.42.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.